The oncogenic activities of CBX1 proved to be attenuable either by AKT pathway inhibition or by targeted silencing of IGF-1R.<h4>Conclusions</h4>The broad overexpression of CBX1 in pan-cancer and specifically in HCC positions it as a putative oncogenic entity. This evidence concerns the gene AKT1 and cancer.